For Which Cancer Types Should I Avoid Maral Supplement?

Highlights

Nutritional supplements and extracts like Maral have benefits and are used by cancer patients and those at-genetic risk of cancer. There is limited or hardly any clinical data available for use of nutritional supplements and foods in cancer patients. Generating clinical evidence of efficacy for cancer through a randomized clinical trial is further infeasible due to variations in genetics and cancer chemotherapy treatments across cancer patients. Hence a different and new approach is needed to find out for which cancers you should not take Maral supplement and why should not take them?

Is it okay to take Maral extracts or supplements for all cancer indications and any chemotherapy treatment? A common belief but a myth is that everything natural can only be of benefit and do no harm. For example, the use of grapefruit with certain medications is not recommended. Another example is the use of spinach with some blood thinning medications can cause adverse interactions and hence to be avoided. For cancer, nutrition including plant-based foods and supplements can influence outcomes and hence an extremely important decision which needs to be made. Hence NIH-National Cancer Institute has a website for nutrition for cancer care for patients which are generalized recommendations and not personalized for cancer indication and treatments.

A frequently asked question by cancer patients and those at-risk is “What Foods and Nutritional Supplements could be beneficial over others for me?”. “Who should not take an extract or supplement and why?”. Generic guidelines like eating only plant-based-foods or avoiding all sugar or adopting a keto diet is a good start but not actionable and personalized enough.

To find answers to questions on extracts and nutritional supplements and foods requires knowledge of contained active ingredients; genetic mutation prevalence for cancer indication; understanding of underlying cancer biology; chemotherapy treatments and mechanism of actions of active ingredients.

Taking Maral extracts or nutritional supplements may benefit Primary Renal Medullary Carcinoma patients on Radiation treatment over Agaricus Mushroom nutritional supplements. But Maral supplements or Maral extracts offer less benefit if on Avastin treatment for Primary Solitary Fibrous Tumor compared to Lions Mane Mushroom. Similarly, taking nutritional supplements Maral may benefit healthy individuals who are at genetic risk of cancer due to mutation of gene VHL over Cannabigerol. But avoid nutritional supplements Maral when at genetic risk of cancer due to mutation of gene ALK.

The takeaway being – cancer, genomics, treatments and other personalized factors will influence decision making to questions like: Are extracts or nutritional supplements Maral beneficial and should not be taken? Why should Maral be not taken? Who should not take Maral? What are side effects of Maral with Avastin chemotherapy? What are the benefits of Maral for cancer? Can Maral help fight cancer and so on.

Whenever there are changes in chemotherapy treatments or cancer tissue genetics – the nutrition may change and hence needs to be re-evaluated. Do consider factors like cancer indication, ongoing chemotherapy treatments and nutritional supplements, age, gender, weight, height, lifestyle and genetics for personalization of nutrition.

Brief Overview

Use of nutritional supplements – vitamins, herbs, minerals, probiotics, and other specialty categories are increasing. Supplements are high concentrations of active ingredients which are also found in different foods. Difference between supplements and foods being that foods contain more than one active ingredient at much lower concentrations. Every active ingredient in an extract or nutritional supplement or food has a unique mechanism of action which can influence nutrition decisions.

These are some example questions which nutrition planning should help answer for you. Should you take supplements Maral? Should you take it when at genetic risk of cancer for mutation of gene VHL? Should you take it when at genetic risk of cancer for mutation of gene ALK? Should you take it when diagnosed with Primary Solitary Fibrous Tumor? Should you take it when diagnosed with Primary Renal Medullary Carcinoma? Should you take it when on Radiation treatment? Should you continue taking it if you change your treatment from Radiation to Avastin? So a general explanation like – it is organic and plant-based or it increases immunity is not sufficient information for making a decision of use of Maral extracts and nutritional supplements.

Cancer

Genetic variations across cancer patients can be different and hence no two cancers are alike. The improved availability of “personalized to genetics” chemotherapy treatments and cancer disease monitoring via blood and saliva have been significant factors to improve outcomes. The earlier the lifestyle and treatment intervention – the better the influence on outcome. Genetic testing has the potential to assess cancer risk and susceptibility early. But for at-risk individuals besides regular monitoring in most cases there are no therapeutic treatment intervention options available. After diagnosis with cancer such as Primary Renal Medullary Carcinoma or Primary Solitary Fibrous Tumor, the treatments get personalized to tumor genomics and factors like staging of disease, age and gender. During cancer remission (after treatment cycle is complete) – monitoring is used for assessment of any relapse and accordingly decide on next steps. A large majority of cancer patients and those at-risk may take nutritional supplements like Maral.

So the question is that are all genetic risks and cancer indications to be considered uniformly when making decisions on the use of Maral extracts or nutritional supplements? Are the biochemical pathway implications of genetic risk for cancer due to mutation of gene VHL the same as due to mutation of gene ALK? Are the implications of Primary Renal Medullary Carcinoma the same as Primary Solitary Fibrous Tumor? Is it one and the same if you are on treatment with Avastin or Radiation?

Maral – An Extract or Nutritional Supplement

Maral is a traditional folk-medicine plant of Siberia. The root derived component of maral is of great interest for pharmaceutical industry and sports medicine. Additionally, maral contains adaptogenic properties having a similar function as ginseng. Some of the purported uses/potential health benefits of maral root include:

• Enhancing athletic performance.
• Mood enhancer.
• Diabetes.
• Erectile dysfunction.
• Anti-cancerous (Skala Ewa et al, Oxid. Med. Cell. Longev., 2018)

Overuse of Maral supplement can lead to side-effects like bleeding disorders due to its ability to function as blood thinner. 

Maral supplements contain many active ingredients including Ecdysterone at different concentration levels. The molecular pathways which are regulated by Maral include PI3K-AKT-MTOR Signaling, MYC Signaling, RAS-RAF Signaling and Endoplasmic Reticulum Stress. These biochemical pathways directly or indirectly regulate specific cancer molecular endpoints like growth, spread and death of cancer cells. Because of this biological regulation – for cancer nutrition, the right choice of supplements like Maral individually or in combination is an important decision to be made. When making decisions on the use of supplement Maral over other nutritional supplements – do consider all these factors.

Who Should not take Maral Supplements and Why?

There is no easy way to answer the question “For which cancers should I not chooseMaral nutritional supplements”. Just like the same chemotherapy treatment does not work across patients, for similar reasons Maral in comparison with other nutritional supplements may be beneficial or not. Along with which cancer and associated genetics – the ongoing treatments, lifestyle habits, height, weight and food allergies are all factors in deciding if Maral should be avoided or not and why.

1. Will Maral Supplements benefit Primary Solitary Fibrous Tumor patients undergoing Avastin treatment?

Primary Solitary Fibrous Tumor is characterized and driven by specific genetic mutations like BRD4, FLI1 and KMT2C leading to biochemical pathway changes in MYC Signaling, Chromatin Remodeling, DNA Repair, Oncogenic Histone Methylation and Amino Acid Metabolism. A cancer treatment like Avastin works through a specific pathway mechanism of action. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach which is effective. In such a condition any food or nutritional supplement which has a contrary effect to the treatment or reduces the overlap should be avoided. As an example, Maral supplement should not be taken for Primary Solitary Fibrous Tumor along with treatment Avastin. Maral supplement impacts the biochemical pathway called MYC Signaling which either promotes drivers of the disease and/or nullifies the treatment effect. Some of the factors which should be considered when choosing nutrition are type of cancer, treatments and supplements being taken currently (if any

2. Will Maral Supplements benefit Primary Renal Medullary Carcinoma Patients undergoing Radiation Treatment?

Primary Renal Medullary Carcinoma is characterized and driven by specific genetic mutations like DICER1, CDKN2B and SPEN leading to biochemical pathway changes in PI3K-AKT-MTOR Signaling, NFKB Signaling, Cell Cycle Checkpoints, Cell Cycle and Notch Signaling. A cancer treatment like Radiation works through specific pathway mechanisms. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach. In such a condition any food or nutritional supplement which supports treatment action or improves the overlap should be considered. As an example, Maral supplements should be considered for Primary Renal Medullary Carcinoma along with the treatment Radiation. Maral supplement impacts pathways/processes like PI3K-AKT-MTOR Signaling which either obstruct drivers of Primary Renal Medullary Carcinoma and/or improve Radiation treatment effect.

3. What about Maral Supplements for Healthy Individuals with ALK Mutation associated Genetic Risk?

Different companies offer panels of genes to be tested for assessing genetic risk to different cancers. These panels cover genes associated with cancers of the breast, ovary, uterus, prostate, and gastrointestinal system and others. Genetic testing of these genes may confirm a diagnosis and help guide treatment and management decisions. Identification of a disease-causing variant may also guide testing and diagnosis of at-risk relatives. ALK is one of the genes generally available in panels for cancer risk testing.

ALK mutation causes biochemical pathways/processes like RAS-RAF Signaling and Growth Factor Signaling to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Maral should not be taken when the genetic panel identifies mutation of ALK for Central Nervous System. Maral impacts pathways/processes like RAS-RAF Signaling and creates adverse conditions with ALK.

4. What about Maral Supplements for Healthy Individuals with VHL Mutation associated Genetic Risk?

VHL is one of the genes available in panels for cancer risk testing. VHL mutation causes biochemical pathways/processes like Endoplasmic Reticulum Stress and Hypoxia to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Maral supplements may be considered when the genetic panel identifies mutations in VHL for Kidney Cancer. Maral impacts pathways/processes like Endoplasmic Reticulum Stress and creates a canceling effect in those individuals with VHL mutation.

* Other Factors are also included like BMI, Treatments, Lifestyle Habits

In Conclusion

It is important to remember that cancer chemotherapy treatments and nutrition are never the same for everyone. Food and nutritional supplements like Maral are chosen by you and can influence outcomes.

“What should I eat?” is a commonly asked question by cancer patients and those at-risk. The answer to this question depends on cancer indication, underlying genetics, current chemotherapy treatments, food allergies, lifestyle information, and food preferences.

The addon.life approach to nutrition personalization uses knowledge of active ingredients contained in foods and nutritional supplements, cancer biology, chemotherapy treatment action and genetic mutation prevalence across cancer indications. addon.life team of clinicians, clinical scientists and engineers are experts in cancer biology focusing only on nutrition personalization for cancer patients and those at-risk.

What food you eat and which supplements you take is a decision you make. Your decision should include consideration of the cancer gene mutations, which cancer, ongoing treatments and supplements, any allergies, lifestyle information, weight, height and habits.

The nutrition planning for cancer from addon is not based on internet searches. It automates the decision making for you based on molecular science implemented by our scientists and software engineers. Irrespective of whether you care to understand the underlying biochemical molecular pathways or not - for nutrition planning for cancer that understanding is needed.

Get started NOW with your nutrition planning by answering questions on the name of cancer, genetic mutations, ongoing treatments and supplements, any allergies, habits, lifestyle, age group and gender.

References

• The role of tumor microenvironment in resistance to anti-angiogenic therapy.
• The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer.
• Effect of β‑ecdysterone on glucocorticoid‑induced apoptosis and autophagy in osteoblasts.
• cBioPortal for Cancer Genomics
• Ecdysterone Accelerates Healing of Radiation-Induced Oral Mucositis in Rats by Increasing Matrix Cell Proliferation.
• Steroids from Helleborus caucasicus reduce cancer cell viability inducing apoptosis and GRP78 down-regulation.
• Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
• cBioPortal for Cancer Genomics